Related Experiment Video

Updated: May 9, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Control of oncogenesis by eIF2α phosphorylation: implications in PTEN and PI3K-Akt signaling and tumor treatment

Antonis E Koromilas1, Zineb Mounir

  • 1Lady Davis Institute, McGill University, Montreal, QC, H3T 1E2, Canada.

Future Oncology (London, England)
|July 11, 2013
PubMed

Insights

mRNA translation is crucial in cancer. Phosphorylated eukaryotic initiation factor 2 alpha (eIF2α) can promote cell survival or death, impacting cancer therapy design.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Stress Response

Background:

  • mRNA translation is vital in tumor development and a target for cancer therapies.
  • Eukaryotic initiation factor 2 (eIF2) regulates mRNA translation initiation.
  • Phosphorylation of eIF2α at S51 triggers protein synthesis inhibition in response to cellular stress.

Purpose of the Study:

  • To investigate the dual role of phosphorylated eIF2α in cell survival and death.
  • To explore the interplay between eIF2α phosphorylation and PI3K-Akt signaling in cancer.

Main Methods:

  • Analysis of eIF2α phosphorylation.
  • Investigation of PI3K-Akt pathway signaling.
  • Assessment of cell fate decisions (survival vs. apoptosis) under different stress conditions.

Main Results:

  • Phosphorylated eIF2α exhibits cytoprotective effects against PI3K-Akt pathway inhibition.
  • Phosphorylated eIF2α can induce apoptosis downstream of PTEN, independent of PI3K-Akt.
  • The cell fate outcome of eIF2α phosphorylation is stimulus-dependent.

Conclusions:

  • The PI3K-Akt and eIF2α phosphorylation pathways have a complex functional interplay.
  • Understanding this interplay is critical for designing effective anti-cancer therapies targeting cell fate.
  • Targeting eIF2α phosphorylation offers a potential strategy for modulating tumor cell survival or death.

More Related Videos

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...